tiprankstipranks
Anika Therapeutics (ANIK)
NASDAQ:ANIK
US Market
ANIK
Anika Therapeutics
RESEARCH TOOLSreports
Want to see ANIK full AI Analyst Report?

Anika Therapeutics (ANIK) Ratios

178 Followers

Anika Therapeutics Ratios

ANIK's free cash flow for Q1 2026 was $0.64. For the 2026 fiscal year, ANIK's free cash flow was decreased by $ and operating cash flow was $-0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.46 4.72 4.88 5.26 6.07
Quick Ratio
 3.37 3.86 3.85 4.47 4.65
Cash Ratio
 1.96 2.62 2.39 2.21 3.09
Solvency Ratio
 -0.12 -0.11 -0.99 -1.17 >-0.01
Operating Cash Flow Ratio
 0.31 0.51 0.23 -0.06 0.16
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 48.08M$ 56.55M$ 64.90M$ 104.94M$ 105.98M
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.13 0.10 0.09
Debt-to-Equity Ratio
 0.18 0.17 0.17 0.13 0.11
Debt-to-Capital Ratio
 0.15 0.14 0.14 0.12 0.10
Long-Term Debt-to-Capital Ratio
 0.15 0.14 0.00 0.00 0.00
Financial Leverage Ratio
 1.34 1.33 1.32 1.27 1.22
Debt Service Coverage Ratio
 -65.28 -1.44 0.00 0.00 0.00
Interest Coverage Ratio
 -103.86 -6.34 0.00 0.00 0.00
Debt to Market Cap
 0.12 0.18 0.00 0.00 0.00
Interest Debt Per Share
 1.77 1.81 1.76 1.89 2.12
Net Debt to EBITDA
 2.50 18.15 -9.83 -2.72 -3.05
Profitability Margins
Gross Profit Margin
58.59%56.56%63.38%68.33%64.33%
EBIT Margin
-9.48%-6.70%-4.25%0.70%3.22%
EBITDA Margin
-5.92%-1.63%2.52%12.47%15.95%
Operating Profit Margin
-10.54%-9.80%-4.25%0.70%3.22%
Pretax Profit Margin
-8.82%-8.25%-2.31%2.61%3.80%
Net Profit Margin
-9.52%-9.64%-47.02%-68.44%-13.05%
Continuous Operations Profit Margin
-9.53%-8.85%-7.36%-2.85%1.93%
Net Income Per EBT
107.84%116.90%2039.98%-2619.36%-343.64%
EBT Per EBIT
83.71%84.22%54.19%373.93%117.82%
Return on Assets (ROA)
-6.17%-5.72%-27.81%-30.55%-4.26%
Return on Equity (ROE)
-7.74%-7.58%-36.62%-38.95%-5.20%
Return on Capital Employed (ROCE)
-7.74%-6.56%-2.84%0.35%1.14%
Return on Invested Capital (ROIC)
-7.74%-6.56%-2.81%-0.38%0.58%
Return on Tangible Assets
-6.51%-6.03%-29.20%-31.74%-5.56%
Earnings Yield
-6.60%-7.90%-23.27%-24.89%-3.45%
Efficiency Ratios
Receivables Turnover
 4.51 4.76 5.08 4.58 3.29
Payables Turnover
 7.59 8.11 7.82 6.18 4.48
Inventory Turnover
 2.11 2.61 1.84 1.57 1.02
Fixed Asset Turnover
 1.78 1.70 1.85 1.86 1.44
Asset Turnover
 0.65 0.59 0.59 0.45 0.33
Working Capital Turnover Ratio
 1.51 1.31 1.08 0.88 0.81
Cash Conversion Cycle
 205.99 171.57 223.04 253.60 386.90
Days of Sales Outstanding
 80.90 76.64 71.82 79.65 111.04
Days of Inventory Outstanding
 173.16 139.91 197.92 233.04 357.43
Days of Payables Outstanding
 48.06 44.99 46.69 59.09 81.56
Operating Cycle
 254.06 216.55 269.74 312.70 468.47
Cash Flow Ratios
Operating Cash Flow Per Share
 0.48 0.78 0.37 -0.12 0.30
Free Cash Flow Per Share
 0.08 0.30 -0.16 -0.49 -0.21
CapEx Per Share
 0.40 0.48 0.53 0.37 0.51
Free Cash Flow to Operating Cash Flow
 0.16 0.39 -0.43 4.04 -0.70
Dividend Paid and CapEx Coverage Ratio
 1.19 1.64 0.70 -0.33 0.59
Capital Expenditure Coverage Ratio
 1.19 1.64 0.70 -0.33 0.59
Operating Cash Flow Coverage Ratio
 0.27 0.46 0.21 -0.06 0.14
Operating Cash Flow to Sales Ratio
 0.06 0.10 0.05 -0.01 0.04
Free Cash Flow Yield
0.58%3.17%-0.96%-2.17%-0.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -18.16 -12.67 -4.30 -4.02 -29.01
Price-to-Sales (P/S) Ratio
 1.71 1.22 2.02 2.75 3.79
Price-to-Book (P/B) Ratio
 1.50 0.96 1.57 1.56 1.51
Price-to-Free Cash Flow (P/FCF) Ratio
 191.53 31.59 -103.95 -46.03 -140.07
Price-to-Operating Cash Flow Ratio
 31.05 12.32 44.85 -185.74 97.76
Price-to-Earnings Growth (PEG) Ratio
 -0.16 0.16 0.13 >-0.01 0.06
Price-to-Fair Value
 1.50 0.96 1.57 1.56 1.51
Enterprise Value Multiple
 -26.40 -56.99 70.40 19.33 20.68
Enterprise Value
 161.45M 104.51M 212.61M 291.11M 375.57M
EV to EBITDA
 -23.45 -56.99 70.40 19.33 20.68
EV to Sales
 1.39 0.93 1.77 2.41 3.30
EV to Free Cash Flow
 155.39 23.96 -91.21 -40.35 -122.06
EV to Operating Cash Flow
 24.95 9.34 39.35 -162.81 85.18
Tangible Book Value Per Share
 9.19 9.33 9.81 13.79 13.98
Shareholders’ Equity Per Share
 9.90 10.01 10.46 14.48 19.61
Tax and Other Ratios
Effective Tax Rate
 -0.08 -0.07 -2.19 2.09 0.49
Revenue Per Share
 8.59 7.87 8.15 8.24 7.82
Net Income Per Share
 -0.82 -0.76 -3.83 -5.64 -1.02
Tax Burden
 1.08 1.17 20.40 -26.19 -3.44
Interest Burden
 1.85 1.23 0.54 3.74 1.18
Research & Development to Revenue
 0.23 0.23 0.21 0.18 0.16
SG&A to Revenue
 0.46 0.44 0.46 0.00 0.00
Stock-Based Compensation to Revenue
 0.12 0.09 0.11 0.13 0.13
Income Quality
 -0.59 -1.03 -0.10 0.02 -0.30
Currency in USD